Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04648293 · ClinicalTrials.gov registry record
Starling Registry Study
A clinical trial, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- 1,207
- Enrollment target
NCT04648293 is a clinical trial that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 1,207 participants.
The verdict
NCT04648293 has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- 1,207 participants
- Enrollment target
Study Summary
Hemodynamic optimization of critically ill patients is a goal for clinicians in order to afford the patient the best possible outcomes. Being able to precisely and rapidly determine patient fluid responsiveness provides the bedside physician and nursing staff the information needed to make critical decisions in regards to the patient's fluid status and management of additional fluids and medications. As fluid management and cardiac output determination are linked to better decision-making and improved outcomes in ICU, the use of a dynamic assessment of fluid responsiveness becomes a key tool for patient management. This study is designed to collect treatment and outcome data on patients that have undergone hemodynamic monitoring in a wide variety of clinical settings, involving a variety of patient diagnoses.
Interventions
- DEVICE Starling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,207 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2024-02-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04648293
The ClinicalTrials.gov registry entry for NCT04648293 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Starling is the first listed.
NCT04648293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04648293 about?
NCT04648293 is a clinical study titled "Starling Registry Study". Hemodynamic optimization of critically ill patients is a goal for clinicians in order to afford the patient the best possible outcomes. Being able to precisely and rapidly determine patient fluid responsiveness provides the bedside physician and nursing staff the information needed to make critical ...
What is the current status of trial NCT04648293?
This trial is currently completed. The enrollment target is 1,207 participants. The study started on 2020-11-16. Estimated completion is 2024-02-21.
What interventions are being tested in trial NCT04648293?
The interventions under investigation include: Starling (DEVICE).
Who is sponsoring clinical trial NCT04648293?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.